Variant report
Variant | nsv825022 |
---|---|
Chromosome Location | chr9:105999365-106004232 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs202023756 | chr9:105999415-105999416 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530879067 | chr9:105999418-105999419 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548994557 | chr9:105999420-105999421 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115006337 | chr9:105999432-105999433 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577553439 | chr9:105999462-105999463 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533521420 | chr9:105999488-105999489 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76840882 | chr9:105999501-105999502 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7854669 | chr9:105999525-105999526 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs542753671 | chr9:105999559-105999560 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373511905 | chr9:105999631-105999632 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139045809 | chr9:105999632-105999633 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34155380 | chr9:105999674-105999675 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575957391 | chr9:105999729-105999730 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149889754 | chr9:105999798-105999799 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144891821 | chr9:105999821-105999822 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546648962 | chr9:105999838-105999839 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182516039 | chr9:105999839-105999840 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140935972 | chr9:105999906-105999907 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549103695 | chr9:105999928-105999929 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568706625 | chr9:105999931-105999932 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185609131 | chr9:105999933-105999934 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551179060 | chr9:105999958-105999959 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570978057 | chr9:105999964-105999965 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7869003 | chr9:105999970-105999971 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs534099688 | chr9:105999982-105999983 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553449338 | chr9:105999984-105999985 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567294822 | chr9:105999988-105999989 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536351959 | chr9:105999999-106000000 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200009287 | chr9:106000004-106000005 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568759069 | chr9:106000022-106000023 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs377296044 | chr9:106000023-106000024 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575890711 | chr9:106000034-106000035 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146730576 | chr9:106000037-106000038 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377222526 | chr9:106000059-106000060 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74691697 | chr9:106000070-106000071 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555285959 | chr9:106000073-106000074 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375018075 | chr9:106000079-106000080 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138294835 | chr9:106000088-106000089 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190061717 | chr9:106000092-106000093 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529293314 | chr9:106000119-106000120 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542688606 | chr9:106000131-106000132 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs370459398 | chr9:106000138-106000139 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199924145 | chr9:106000141-106000142 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs199622955 | chr9:106000146-106000147 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12553379 | chr9:106000147-106000148 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535756784 | chr9:106000198-106000199 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571431440 | chr9:106000217-106000218 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs527582143 | chr9:106000231-106000232 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368402762 | chr9:106000297-106000298 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs547716440 | chr9:106000302-106000303 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Fukuyama congenital muscular dystrophy | 21572526 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:105999400-106000200 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
2 | chr9:105999600-106000200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
3 | chr9:105999600-106000400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
4 | chr9:105999800-106000200 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr9:105999800-106000200 | Active TSS | H9 Cell Line | embryonic stem cell |
6 | chr9:105999800-106000200 | Active TSS | HUES48 Cell Line | embryonic stem cell |
7 | chr9:105999800-106000200 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
8 | chr9:106000000-106000200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr9:106000200-106004000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
10 | chr9:106000200-106004200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr9:106000200-106004400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr9:106000200-106007400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
13 | chr9:106004000-106004400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr9:106004200-106004800 | Enhancers | HUES48 Cell Line | embryonic stem cell |